Status: Not yet recruiting
Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma
This is a pilot study evaluating the efficacy and safety of ivonescimab in subjects with advanced or metastatic cutaneous angiosarcoma who have previously been treated with taxane-based chemotherapy.
Participants needed: 10
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Aug 20, 2026Locations: 1
Eligibility criteria
Patients must have histologically confirmed cutaneous angiosarcoma that is advan... [+17]
Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for n... [+33]